Articles

Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease

Josep Carreras Leukemia Research Institute, Cell Therapy Program of the University of Barcelona, Faculty of Medicine, Barcelona, Spain
GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Servicio de Hematología, Hospital Clínico San Carlos, Madrid, Spain
Josep Carreras Leukemia Research Institute, Cell Therapy Program of the University of Barcelona, Faculty of Medicine, Barcelona, Spain
Josep Carreras Leukemia Research Institute, Cell Therapy Program of the University of Barcelona, Faculty of Medicine, Barcelona, Spain
Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada, Ottawa, Ontario, Canada.
Department of Hematology, University Hospital of Salamanca and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain
Department of Neurology, Neurovascular Area, Clinical Neurosciences Research Laboratory, Hospital Clínico-Health Research Institute of Santiago de Compostela, Spain
Servicio de Hematología, Hospital Clínico de Málaga, Málaga, Spain
Servicio de Hematología, Hospital Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain
Sección de Oncohematología Pediátrica, Hospital Virgen de Arrixaca, Murcia, Spain
Servicio de Hematología, Hospital Universitario Virgen de las Nieves, Granada, Spain
Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain
Josep Carreras Leukemia Research Institute, Cell Therapy Program of the University of Barcelona, Faculty of Medicine, Barcelona, Spain;Instituciò Catalana de Reserca i Estudis Avançats (ICREA), Barcellona, Spain
Vol. 99 No. 7 (2014): July, 2014 https://doi.org/10.3324/haematol.2014.103580